Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.55 USD
+0.82 (5.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.56 +0.01 (0.06%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Earnings News For RCUS
-
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates
-
Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
-
Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q1 Earnings Expected to Decline
-
Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
-
Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates
-
Arcus Biosciences, Inc. (RCUS) Q4 Earnings and Revenues Surpass Estimates
-
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q3 Earnings Expected to Decline
-
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Lags Revenue Estimates
-
Will Arcus Biosciences, Inc. (RCUS) Report Negative Q2 Earnings? What You Should Know
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates
-
Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Misses Revenue Estimates
-
Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q1 Earnings Expected to Decline
-
Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
-
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates